Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetr...
Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites
About this item
Full title
Author / Creator
Christopoulos, Katerina A , Colasanti, Jonathan , Johnson, Mallory O , Diaz Tsuzuki, Manami , Erguera, Xavier A , Flores, Rey , Kerman, Jared , Dance, Kaylin , Sauceda, John A , Neilands, Torsten B , Dilworth, Samantha E , Koester, Kimberly A , Gutierrez, Jose , Schneider, John A , Montgomery, Elizabeth and McNulty, Moira C
Publisher
United States: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
United States: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementation phases.
Alternative Titles
Full title
Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9301580
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9301580
Other Identifiers
ISSN
2328-8957
E-ISSN
2328-8957
DOI
10.1093/ofid/ofac293
